RxDoctor Payments Data

Meredith Schweitzer, DO

Family Medicine · Antioch, TNNPI 1699861559

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.7% of the total across 1,877 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$37,460in general payments, 2019–2025

Across 1,877 payments — averaging $19.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$7K
  • AstraZeneca$3K
  • Amgen$2K
  • AbbVie$2K
  • Bayer$2K
  • Lilly USA, LLC$2K
  • plus $20K from 54 others

What the payments were for

  • Travel & lodging$3541%
  • Food & beverage$36,97599%
  • Education$1310%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk365$6,698
AstraZeneca105$3,085
Amgen(2 entities)96$2,171
AbbVie(2 entities)119$2,040
Bayer58$1,773
Lilly USA, LLC128$1,723
Pfizer96$1,588
GSK70$1,277
Boehringer Ingelheim83$1,219
Otsuka America Pharmaceutical, Inc.49$1,068
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)32$1,051
Novartis31$874
Merck68$872
Sanofi-aventis U.S. LLC56$820
Biohaven Pharmaceutical Holding Company Ltd.18$794
Takeda Pharmaceuticals U.S.A., Inc.56$746
Gilead39$596
Astellas Pharma US Inc30$585
Axsome Therapeutics, Inc.21$577
Johnson & Johnson36$573
Biohaven Pharmaceuticals, Inc.14$527
Exact Sciences20$524
Esperion Therapeutics, Inc.17$498
Upsher-smith Laboratories LLC38$468
Xeris Pharmaceuticals, Inc.20$462
Eisai Inc.22$441
BETA Bionics, Inc.5$408
Shield Therapeutics Inc14$406
Zealand Pharma US, Inc.8$383
Mannkind Corporation13$292
Insulet Corporation13$292
Sumitomo Pharma America, Inc.17$286
Amarin Pharma, Inc.17$245
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC14$243
Dexcom, Inc.11$221
Cequr Corporation1$177
Phathom Pharmaceuticals, Inc.4$161
Radius Health, Inc.11$154
Lundbeck LLC7$146
Dynavax Technologies Corporation9$135
Arbor Pharmaceuticals, Inc.7$106
Optinose US, Inc.4$99
Edwards Lifesciences4$95
Kowa Pharmaceuticals America, Inc.6$90
Antares Pharma, Inc.3$51
Neurocrine Biosciences, Inc.2$46
Ascensia Diabetes Care US Inc.2$44
Impel Pharmaceuticals Inc.2$41
Inspire Medical Systems, Inc.1$37
Nevro Corp.2$28
Valeritas, Inc.1$26
Currax Pharmaceuticals LLC1$25
Viiv Healthcare Company1$25
Zyla Life Sciences, Inc.2$24
Amphastar Pharmaceuticals, Inc.1$18
Corcept Therapeutics1$16
Sunovion Pharmaceuticals Inc.1$16
Ultragenyx Pharmaceutical Inc.1$15
Sanofi Pasteur Inc.1$15
Azurity Pharmaceuticals, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,460 in reported general payments places this provider in the 95th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$15,633
Medicare patients
28
Services billed
239

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide24$31,704
FarxigaDapagliflozin Propanediol18$26,358
EliquisApixaban18$13,678
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$8,027
Ezetimibe24$1,538
Rosuvastatin Calcium94$1,334
Raloxifene Hcl22$1,126
Atorvastatin Calcium54$670
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide20$654
Albuterol Sulfate HfaAlbuterol Sulfate25$619
Levothyroxine Sodium72$614
Pravastatin Sodium30$515
Alendronate Sodium46$420
Bupropion XlBupropion Hcl12$413
Losartan Potassium36$408

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$3,085$34,38531 claims
Novo NordiskOzempic$6,698$31,70424 claims
PfizerEliquis$1,588$13,67818 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Antioch

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →